Safety in Abdominal Aortic Aneurysm Surveillance Programs

Abdominal Aortic Aneurysm (AAA) rupture rate in the UK justifies the current surveillance programs and bring ease to some physicians that at some point have cast a shadow on their efficacy. This study also endorses reference thresholds to intervene patients.

El tratamiento endovascular parece superior a la cirugía en aneurismas rotosIn 2009, the UK National Health Service (NHS) implemented a AAA national surveillance scheme where men over 65 were eligible for screening. Those with ≥5.5 cm aneurysms were sent to consult with a vascular surgeon, while those with smaller aneurysms were invited to enter an ultrasound surveillance program.

 

AAA treatment guidelines were published in 2003, estimating a 3 to 15% rupture risk for aneurysms between 5 and 5.9 cm. More recent guidelines have estimated a 1% rupture risk a year for aneurysms under 5.5 cm.


Read also: Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference.


This study looked at over 18,000 men between 2009 and 2017 that took part in the surveillance scheme and starting with AAA between 3 and 5.5 cm. The study did not include women, since AAA incidence in women is significantly lower.

 

During the follow up period, some 1763 patients reached 5.5 cm or higher measures and were referred to a peripheral vascular physician for definite treatment. Some 83 with smaller aneurysms were also sent to a specialist based on their symptoms, rapid growth and other alarming signs. Finally, 31 patients had aneurysm rupture, and 29 of these patients died.

 

These figures result in an estimated risk of 1 in 100 patients/year for all diameters bellow 5.5 cm.


Read also: Risk of Colonic Ischemia after Abdominal Aortic Aneurysm Repair.


Risk is in direct correlation with diameter: it goes from 0.03% for smaller aneurysms (between 3 and 4.4 cm) to 0.4% for AAA right below the reference threshold (5.0 to 5.4 cm).

 

Since rupture risk in this cohort is so low, we can conclude that the surveillance program is safe.

 

Original title: Safety of men with small and medium abdominal aortic aneurysms under surveillance in the national health service screening program.

Reference: Oliver-Williams C et al. Circulation. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...